Kendra S Carmon

13PUBLICATIONS
22CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 27, 2026
Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis.

|Aug 18, 2025
Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer.

Yukimatsu Toh, Ling Wu, Jianghua Tu

|Jul 16, 2025
Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models.

Peyton C High, Zhengdong Liang, Cara Guernsey-Biddle

|Dec 18, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton C High

|Nov 28, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton High

|Jul 27, 2024
Antitumor Activity of a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma.

Jianghua Tu, Yukimatsu Toh, Adela M Aldana

Pageof 3

Frequent Collaborators

5 joint publications

Joan Jacob

4 joint publications

Shraddha Subramanian

3 joint publications

Ali Azhdarinia

3 joint publications

Qingyun J Liu